Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medison Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10824
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medison Pharma Ltd (Medison) is marketing company which supplies and markets health care solutions to health maintenance organizations (HMO’s), medical centers, and physicians in Israel and Romania. The company offers pharmaceuticals, medical devices, and diagnostic products in the areas of neurology, oncology, human genetics, nephrology, ADHD, cardiology, hematology, aesthetics, endocrinology, infectious diseases, and allergology. Medison provides integrated services for international healthcare companies to expand their presence in Israel and Romanian healthcare markets. The company works in partnership with multinational companies which include Amgen, Inc., Ipsen SA, Shire Plc, and others. It has operations with office in Romania. Medison is headquartered in Petach Tikva, Israel.

Medison Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Camurus and Medison Pharma Enter into Agreement 11
Tesaro and Medison Pharma Enter into Distribution Agreement 12
Licensing Agreements 13
Medison Pharma Enters into Licensing Agreement with Puma Biotechnology 13
Medison Pharma Enters into Licensing Agreement with Resverlogix 14
Apeiron Biologics Enters into Licensing Agreement with Medison Pharma for APN311 15
Regulon Enters Into Licensing Agreement With Medison For Lipoplatin 16
Medison Pharma Ltd – Key Competitors 17
Medison Pharma Ltd – Key Employees 18
Medison Pharma Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Camurus and Medison Pharma Enter into Agreement 11
Tesaro and Medison Pharma Enter into Distribution Agreement 12
Medison Pharma Enters into Licensing Agreement with Puma Biotechnology 13
Medison Pharma Enters into Licensing Agreement with Resverlogix 14
Apeiron Biologics Enters into Licensing Agreement with Medison Pharma for APN311 15
Regulon Enters Into Licensing Agreement With Medison For Lipoplatin 16
Medison Pharma Ltd, Key Competitors 17
Medison Pharma Ltd, Key Employees 18
Medison Pharma Ltd, Subsidiaries 19

List of Figures
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medison Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medison Pharma Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medison Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiwan Tobacco and Liquor Corporation:企業概要及びSWOT分析
    Summary Canadean's "Taiwan Tobacco and Liquor Corporation: Consumer Packaged Goods - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, busines …
  • SGS SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' SGS SA Mergers and Acquisitions …
  • Brookdale Senior Living, Inc.:企業の戦略・SWOT・財務分析
    Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report Summary Brookdale Senior Living, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • W.H. Brakspear and Sons Limited(食品サービス分野):企業概要及びSWOT分析
    Product Synopsis Canadean's "W.H. Brakspear and Sons Limited: Foodservice - Company Profile and SWOT Report" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Mangalore Chemicals & Fertilizers Limited (MANGCHEFER):企業財務及び戦略的SWOT分析
    Summary Mangalore Chemicals & Fertilizers Limited (MCFL) a subsidiary of Zuari Fertilisers and Chemicals Limited is a fertilizer company that manufactures fertilizers, plant nutrition products, plant protection chemicals, and other products. The company’s products include urea, di-ammonium phosphate …
  • Jollibee Foods Corporation:企業の戦略・SWOT・財務分析
    SummaryJollibee Foods Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Fujita Kanko Inc.:企業の戦略・SWOT・財務分析
    SummaryFujita Kanko Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findi …
  • Mitobridge Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitobridge Inc (Mitobridge), formerly Mitokyne Inc, a subsidiary of Astellas Pharma Inc is a drug development company that discovers and develops small molecule therapeutics that recovers mitochondrial functions. The company develops therapies for rare diseases and expands into more common d …
  • Forum Energy Technologies Inc:企業の戦略・SWOT・財務情報
    Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ess Dee Aluminium Limited:企業の戦略・SWOT・財務分析
    SummaryEss Dee Aluminium Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • Ability Pharmaceuticals SL:企業のM&A・提携動向(医療分野)
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly known as AB Therapeutics S.L., is a clinical stage biopharmaceutical company that focuses on drug discovery and development. The company develops human therapeutics to treat various cancers and other indications with unmet medical needs. …
  • Leica Microsystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary Leica Microsystems GmbH (Leica), a subsidiary of Danaher Corp is a medical device company that manufactures microstructures. The company manufactures, and markets microscopes and scientific instruments. Its products include light microscopes, confocal microscopes, stereo microscopes and macr …
  • BYD Co Ltd (1211)-エネルギー分野:企業M&A・提携分析
    Summary BYD Company Limited (BYD) designs, manufactures and sells rechargeable batteries, photovoltaic products, handset components, and other electronic products. It also offers whole product assembly services to clients. As part of its automobile business, the company manufactures and offers tradi …
  • Terra Energy Corp. (TT):企業の財務及び戦略的SWOT分析
    Summary Terra Energy Corp. (Terra Energy) is an oil and gas company that acquires and explores oil and natural gas properties. The company’s oil and gas portfolio are located in northeastern British Columbia and the Peace River Arch region of Alberta. Its producing areas in British Columbia include …
  • Intuit Inc.:企業のM&A・提携・投資分析
    Intuit Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intuit Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Paramount Gold and Silver Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Paramount Gold and Silver Corp. …
  • Atwood Oceanics Inc-石油・ガス分野:企業M&A・提携分析
    Summary Atwood Oceanics, Inc. (Atwood) is an offshore drilling contractor, which offers drilling and completion solutions to the oil and gas industry. The company owns a diversified fleet of mobile offshore drilling units in the US Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshor …
  • Laredo Petroleum, Inc. (LPI)-石油・ガス分野:企業M&A・提携分析
    Summary Laredo Petroleum, Inc. (Laredo), formerly known as Laredo Petroleum Holdings, Inc., is an independent energy company that acquires assets, and explores for, develops and produces oil and natural gas properties. It also gathers oil and liquids-rich natural gas from its properties. The company …
  • Mediwatch Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mediwatch Plc Mergers and Acqui …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆